Focusing on Prediabetes Is the Key to Reversing the Rise in Diabetes
May 21st 2015Evidence-Based Diabetes Management invited the YMCA's Jonathan Lever, vice president for health strategy and innovation, to comment on his organization's involvement with the National Diabetes Prevention Program.
Toujeo and Afrezza: New and Improved Insulins, Limited by FDA Labeling Constraints
May 19th 2015Two new insulins marketed by Sanofi offer improved options for patients: Toujeo is longer acting than its predecessor, Lantus. Afrezza, an inhaled insulin, is gaining praise from patients, if not from Wall Street.
Preventing Ketoacidosis Complications in Diabetes
May 19th 2015Risk factors associated with diabetic ketoacidosis typically do not change. Preventing DKA should focus on identification of those most at risk and educating them good self-care to avoid incidents.